Viewing Study NCT01318135


Ignite Creation Date: 2025-12-24 @ 10:03 PM
Ignite Modification Date: 2025-12-25 @ 7:40 PM
Study NCT ID: NCT01318135
Status: COMPLETED
Last Update Posted: 2012-08-16
First Post: 2011-03-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan
Sponsor: Takeda
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SYR-322/OCT-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators